A review and update for the Centers for Medicare and Medicaid Services (CMS) Merit-based Incentive Payment System (MIPS) by in 2022 with Barbara Rubel and Claudia Murray with information they presented at this year's RBMA meeting.

The SGLT2 inhibitor is already known as an effective medication for both type 2 diabetes and heart failure.

Five out of eight filtering face piece (FFP-3) masks studied contained ferromagnetic components.

The medication failed a routine dissolution test, meaning it could lose its effectiveness. 

A new advisory from the U.S. Surgeon General included several recommendations for addressing burnout.

Eric Williamson, MD, president of the Society of Cardiovascular Computed Tomography (SCCT) and professor of radiology at Mayo Clinic, explains how the iodine contrast shortage is causing issues for cardiac CT imaging and ways this can be mitigated.

Post-treatment changes may mask some of the subtle, early signs of recurring breast cancer on traditional mammography, an Academic Radiology editorial explains.

The Food & Drug Administration has drafted guidelines to help U.S. healthcare better prepare for and respond to events associated with these situations.

A multidisciplinary panel convened by the ACR has developed a set of quality measures aimed at boosting rates of appropriate follow-up care for patients with noncritical but actionable incidental findings.

The medication, sold under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.